COGT
Price
$4.42
Change
-$0.04 (-0.89%)
Updated
Apr 24, 02:21 PM (EDT)
Capitalization
494.11M
19 days until earnings call
SPHDF
Price
$17.54
Change
+$1.09 (+6.63%)
Updated
Apr 23 closing price
Capitalization
226.3M
Ad is loading...

COGT vs SPHDF

Header iconCOGT vs SPHDF Comparison
Open Charts COGT vs SPHDFBanner chart's image
Cogent Biosciences
Price$4.42
Change-$0.04 (-0.89%)
Volume$625
Capitalization494.11M
Santhera Pharmaceuticals Holdings
Price$17.54
Change+$1.09 (+6.63%)
Volume$100
Capitalization226.3M
COGT vs SPHDF Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. SPHDF commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and SPHDF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (COGT: $4.47 vs. SPHDF: $17.54)
Brand notoriety: COGT and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 63% vs. SPHDF: 20%
Market capitalization -- COGT: $494.11M vs. SPHDF: $226.3M
COGT [@Biotechnology] is valued at $494.11M. SPHDF’s [@Biotechnology] market capitalization is $226.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileSPHDF’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • SPHDF’s FA Score: 1 green, 4 red.
According to our system of comparison, SPHDF is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 6 TA indicator(s) are bullish.

  • COGT’s TA Score: 6 bullish, 2 bearish.

Price Growth

COGT (@Biotechnology) experienced а +4.68% price change this week, while SPHDF (@Biotechnology) price change was +6.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($494M) has a higher market cap than SPHDF($226M). SPHDF YTD gains are higher at: 86.165 vs. COGT (-42.692).
COGTSPHDFCOGT / SPHDF
Capitalization494M226M219%
EBITDA-271.59MN/A-
Gain YTD-42.69286.165-50%
P/E RatioN/A2.47-
Revenue0N/A-
Total Cash287MN/A-
Total Debt17.5MN/A-
FUNDAMENTALS RATINGS
COGT vs SPHDF: Fundamental Ratings
COGT
SPHDF
OUTLOOK RATING
1..100
398
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
9537
P/E GROWTH RATING
1..100
10010
SEASONALITY SCORE
1..100
n/a31

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPHDF's Valuation (60) in the null industry is in the same range as COGT (81) in the Miscellaneous industry. This means that SPHDF’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (78) in the Miscellaneous industry is in the same range as SPHDF (100) in the null industry. This means that COGT’s stock grew similarly to SPHDF’s over the last 12 months.

COGT's SMR Rating (96) in the Miscellaneous industry is in the same range as SPHDF (100) in the null industry. This means that COGT’s stock grew similarly to SPHDF’s over the last 12 months.

SPHDF's Price Growth Rating (37) in the null industry is somewhat better than the same rating for COGT (95) in the Miscellaneous industry. This means that SPHDF’s stock grew somewhat faster than COGT’s over the last 12 months.

SPHDF's P/E Growth Rating (10) in the null industry is significantly better than the same rating for COGT (100) in the Miscellaneous industry. This means that SPHDF’s stock grew significantly faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGT
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 17 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRXP1.980.07
+3.66%
NRX Pharmaceuticals
BRDG8.890.22
+2.54%
Bridge Investment Group Holdings
GENI10.470.15
+1.45%
Genius Sports Limited
COLM65.250.91
+1.41%
Columbia Sportswear Company
PAYX143.22-0.07
-0.05%
Paychex

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+3.00%
SPHDF - COGT
63%
Loosely correlated
+6.61%
ETNB - COGT
50%
Loosely correlated
+0.92%
ARWR - COGT
50%
Loosely correlated
+5.26%
CRNX - COGT
47%
Loosely correlated
+3.55%
RCKT - COGT
47%
Loosely correlated
+2.44%
More

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with TRML. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
+6.61%
TRML - SPHDF
78%
Closely correlated
+3.12%
COGT - SPHDF
63%
Loosely correlated
+3.00%
MEOBF - SPHDF
50%
Loosely correlated
N/A
KROS - SPHDF
38%
Loosely correlated
+2.95%
CYTOF - SPHDF
35%
Loosely correlated
-1.41%
More